These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28234606)

  • 21. Medical abortion in China.
    Wu S
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):197-9, 204. PubMed ID: 10846339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flexible mifepristone and misoprostol administration interval for first-trimester medical termination.
    Wedisinghe L; Elsandabesee D
    Contraception; 2010 Apr; 81(4):269-74. PubMed ID: 20227541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation.
    Tang OS; Xu J; Cheng L; Lee SW; Ho PC
    Hum Reprod; 2002 Jul; 17(7):1738-40. PubMed ID: 12093832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
    Chai J; Ho PC
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):291-4. PubMed ID: 24135383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
    Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication Abortion Up to 70 Days of Gestation.
    Practice Bulletins—Gynecology, the Society of Family Planning
    Contraception; 2020 Oct; 102(4):225-236. PubMed ID: 32807380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
    Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.
    Creinin MD; Potter C; Holovanisin M; Janczukiewicz L; Pymar HC; Schwartz JL; Meyn L
    Am J Obstet Gynecol; 2003 Mar; 188(3):664-9. PubMed ID: 12634638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous use of mifepristone and misoprostol for early pregnancy termination.
    Li YT; Hsieh JC; Hou GQ; Chen TH; Chu YC; Lin TC; Kuan LC; Lin M; Tang HH; Kuo TC
    Taiwan J Obstet Gynecol; 2011 Mar; 50(1):11-4. PubMed ID: 21482367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on second trimester medical abortion.
    Lerma K; Shaw KA
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):413-418. PubMed ID: 28922193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can vaginal misoprostol be administered 1 to 3 days after mifepristone without loss of efficacy or an increase in adverse events?
    Richardson CR
    J Fam Pract; 2001 Jan; 50(1):9. PubMed ID: 11195490
    [No Abstract]   [Full Text] [Related]  

  • 38. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
    Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
    Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Legal termination of pregnancy.
    Nash ES
    S Afr Med J; 2003 Feb; 93(2):87. PubMed ID: 12640868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.